SPECIMEN #LIFE-EXT
Verified
MineralsLife Extension
Potassium with Extend-Release Magnesium
Daily magnesium supplementation with a trace amount of potassium support.. The magnesium component is well-dosed and uses a premium, extended-release form. However, the potassium dose is negligible due to regulatory limits, making it ineffective for meaningful potassium supplementation. This significant weakness pulls the overall score down per the hero product rule.
7.5/10
VERY GOODMagnesium at 250mg with extended-release technology (ZumXR) is 63% of optimal 400mg but above minimum effective. The extended release is smart for magnesium absorption. Potassium at 99mg hits the FDA-mandated supplement limit. The magnesium is the real star here, and it delivers well.
2 ingredientsCapsules60 servings
Evidence
7.0
Dosing
3.4
Synergy
6.0
What We Like
- Premium extended-release magnesium form (ZümXR®)
- Adequate magnesium dose
Watch Out For
- Severely underdosed potassium
- Misleading product name given potassium dose
What We Analyzed
Verified Supplement Facts
Every dose checked against clinical research
We analyzed the actual supplement facts panel for this product. Every ingredient dose below was cross-referenced with published clinical trials to determine if it matches what studies actually use.
11 ingredients analyzed1 underdosed
Source: Official product page
Ingredient Breakdown
1 adequate1 underdosed
Clinical Adequate Underdosed Overdosed|Bar = % of clinical dose
IngredientDoseStatusvs. Clinical
In our database (click to learn more) Not yet reviewed
Other Ingredients(inactive)
vegetable cellulose (capsule), ethylcellulose, microcrystalline cellulose, medium chain triglycerides, stearic acid, rice concentrate, hypromellose, oleic acid, silica
Our Analysis
Personalized Deep Analysis
See exactly how this fits your health profile. What works for you, what doesn't, and whether you're getting your money's worth.
Unlock with ProTaking other supplements too?
Check your full stack for interactions, redundancies, and gaps. Takes 30 seconds.
0 views